Skip to main content
Fig. 2 | Cancer Cell International

Fig. 2

From: FABP7 is a potential biomarker to predict response to neoadjuvant chemotherapy for breast cancer

Fig. 2

Higher expression of FABP7 correlated with low expression of ESR1, GATA3 and FoxA1. a The mRNA expression level of FABP7 in TNBC and not-TNBC patients. b The mRNA expression level of FABP7 in breast cancer patients with ER (−) and ER (+). c Gene correlation targeted analysis between FABP7 and ESR1. d Gene correlation targeted analysis between FABP7 and GATA3. e Gene correlation targeted analysis between FABP7 and FOXA1. f Correlation map for all patients among FABP7, ESR1, GATA3 and FOXA1

Back to article page